Effects of aspirin on serum C-reactive protein and interleukin-6 levels in patients with type 2 diabetes without cardiovascular disease: a randomized placebo-controlled crossover trial. [electronic resource]
Producer: 20090220Description: 668-74 p. digitalISSN:- 1463-1326
- Aspirin -- administration & dosage
- Atherosclerosis -- drug therapy
- C-Reactive Protein -- drug effects
- Cross-Over Studies
- Diabetes Mellitus, Type 2 -- drug therapy
- Diabetic Angiopathies -- prevention & control
- Female
- Humans
- Interleukin-6 -- metabolism
- Male
- Middle Aged
- Platelet Aggregation Inhibitors -- administration & dosage
- Prospective Studies
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.